Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs
ULTREC
Safety of a Management Strategy Based on Colour Doppler ULTrasound and D-Dimer Testing for the Diagnosis Exclusion of RECurrent Deep Vein Thrombosis of the Lower Limbs. The ULTREC Project
2 other identifiers
interventional
466
1 country
45
Brief Summary
The purpose is to assess the safety of a management strategy based on colour doppler ultrasound (CDUS) and D-Dimer test results for the diagnosis exclusion of recurrent deep vein thrombosis (DVT) of the lower limbs. DVT recurrence requires using anticoagulant treatment to prevent thrombosis progression. Given an increased bleeding risk with prolonged treatment, an accurate diagnosis for recurrence is needed. However, the diagnosis of a new thrombosis in a previously involved leg is difficult. Imaging modalities and criteria that are currently used for the diagnosis may be equivocal and unable to discriminate between an old clot and a new one recently developed at the same site. An increase in vein diameter after vein compression by the ultrasound probe was suggested as a diagnostic criterion for a new DVT. This method has many limitations in clinical practice, mainly a lack of availability of a previous measurement and a poor inter-observer agreement. Colour Doppler ultrasound enables to study both the thrombus and the blood flow characteristics that might help to overcome these limitations. CDUS is a well-known method for the diagnosis of vascular diseases and is used in every day clinical practice for the diagnosis of a first DVT and DVT recurrence but CDUS has never been assessed for DVT recurrence in a study. The diagnosis of DVT recurrence may be easily established using the same criteria as for a first DVT episode. Our hypothesis is that CDUS associated with D-Dimer can safely rule out the diagnosis of DVT recurrence while maintaining a good specificity. The strategy consists in performing first a CDUS that helps to classify patients as having (positive CDUS) or not having (negative CDUS) a new thrombosis. In the case of an equivocal CDUS, a D-Dimer test is performed. If the D-dimer is normal, the diagnosis of DVT recurrence is ruled out and the patient is not treated. If the D-dimer is abnormal, the diagnosis cannot be excluded nor confirmed and a second CDUS is performed on D7±2. Meanwhile, patients are not treated by anticoagulants. An unchanged CDUS on D7±2 qualifies patients as free from a new DVT and they are not treated. Conversely a change in CDUS qualifies patients as having a new DVT which requires anticoagulant treatment. All patients have a 3-month follow-up for the assessment of potential venous thromboembolic events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2020
Typical duration for not_applicable
45 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2019
CompletedFirst Posted
Study publicly available on registry
March 11, 2019
CompletedStudy Start
First participant enrolled
January 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2023
CompletedApril 13, 2026
April 1, 2026
3 years
March 8, 2019
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adjudicated symptomatic venous thromboembolic events
Rate of adjudicated symptomatic venous thromboembolic (VTE) events among patients not treated by anticoagulants according to the diagnostic strategy The criteria for recurrent VTE include: * objectively confirmed pulmonary embolism (PE) by either CT pulmonary angiography or ventilation-perfusion scan, * death due to PE, * and recurrent DVT of the leg Death, cause of death, VTE comprising isolated proximal or distal DVT and PE (with or without DVT), will be adjudicated by an independent clinical event committee blinded to the classification of the diagnostic strategy.
3 months
Secondary Outcomes (6)
Prevalence of deep vein thrombosis recurrence
Up to 3 months
Proportion of patients tested negative
A day if the diagnostic strategy is conclusive (either positive or negative) at day 0, or 7 days if it is inconclusive
Proportion of complete patients
3 months
Bleeding complication occurrence
3 months
Correlation of possible strategy failure in not anticoagulated patients and patient characteristics
3 months
- +1 more secondary outcomes
Study Arms (1)
Diagnostic strategy
EXPERIMENTALColour doppler ultrasound (CDUS) with or without D-dimer test to rule-in or rule-out deep vein thrombosis recurrence
Interventions
* Positive CDUS: anticoagulant treatment * Negative CDUS: no anticoagulant treatment * Non diagnostic CDUS : reference to routine D-dimer test * Negative test : no anticoagulant treatment * Positive test : second CDUS 7 days (±2) after first one * No change in CDUS : no anticoagulant treatment * Change in CDUS : anticoagulant treatment
Eligibility Criteria
You may qualify if:
- Age \>= 18 years
- Known history of objectively documented deep vein thrombosis of the lower limb (with or without pulmonary embolism)
- Out-patients referred for clinically suspected acute recurrent ipsilateral DVT of the lower limb i.e. the occurrence of new symptoms and signs of DVT or the increase of symptoms and signs in patients with post-thrombotic syndrome
- Patients covered by social security or equivalent regimen
- Signed and dated informed consent
You may not qualify if:
- Known current pregnancy
- Any condition, which, in the opinion of the investigator may prevent him from performing the colour doppler ultrasound test (plaster cast, inaccessible vein segment after abdominal or pelvic surgery, or other causes that may lead to a technically inadequate CDUS)
- Therapeutic anticoagulation for more than 48 hours in the two days prior to consent or a need for long term anticoagulation
- Prophylactic anticoagulation for more than 48 hours in the two days prior to consent
- Clinical symptoms of pulmonary embolism
- Life expectancy less than 3 months
- Patient unable to adhere to protocol or follow-up visits and contacts
- Participants under legal guardianship or incapacitation
- Patient already enrolled in a deep vein thrombosis (DVT) diagnostic research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (45)
Centre Hospitalier de Vichy
Vichy, Allier, 03200, France
Centre Hospitalier Universitaire de Nice
Nice, Alpes-Maritimes, 06001, France
Centre Hospitalier de Carcassonne
Carcassonne, Aude, 1060, France
Centre d'angiologie
Carcassonne, Aude, 11000, France
APHM La Timone
Marseille, Bouches Du Rhône, 13385, France
Cabinet libéral Pung
Aubagne, Bouches-du-Rhône, 13400, France
Cabinet libéral Dias
Istres, Bouches-du-Rhône, 13800, France
Cabinet libéral Sidoli
Marseille, Bouches-du-Rhône, 13003, France
Cabinet libéral El Haddad
Marseille, Bouches-du-Rhône, 13011, France
Cabinet libéral De Mari
Ajaccio, Corse Du Sud, 20090, France
Cabinet libéral Secondi
Ajaccio, Corse Du Sud, 20090, France
Centre Hospitalier Universitaire Bocage
Dijon, Cote d'Or, 21079, France
Centre Hospitalier Universitaire François Mitterrand
Dijon, Côte d'Or, 21079, France
Centre hospitalier Universitaire Cavale Blanche
Brest, Finistère, 29609, France
Centre Hospitalier Universitaire de Nîmes
Nîmes, Gard, 30029, France
Centre Hospitalier d'Auch
Auch, Gers, 32000, France
Cabinet libéral Cazaux
Auch, Gers, France
Hôpital Saint André
Bordeaux, Gironde, 33075, France
Centre de medicine vasculaire interventionnel
Langon, Gironde, 33210, France
Cabinet libéral Casanova
Bastia, Haute Corse, 20600, France
Cabinet libéral Bonavita
Bastia, Haute-Corse, 20200, France
Cabinet libéral Bourrinet
Balma, Haute-Garonne, 31130, France
Centre Hospitalier Universitaire Rangueil
Toulouse, Haute-Garonne, 31059, France
Clinique Rive Gauche
Toulouse, Haute-Garonne, 31076, France
Cabinet libéral Wagner
Lourdes, Hautes-Pyrénées, 65100, France
Cabinet libéral Esteve
Tarbes, Hautes-Pyrénées, 65000, France
Centre Hospitalier Universitaire de Montpellier
Montpellier, Hérault, 34295, France
Centre Hospitalier Universitaire de Rennes
Rennes, Ille-et-Vilaine, 35033, France
Centre Hospitalier Universitaire de Grenoble
Grenoble, Isère, 38700, France
Centre Hospitalier Universitaire d'Angers
Angers, Maine-et-Loire, 49933, France
Centre Hospitalier Universitaire de Nancy
Nancy, Meurthe Et Moselle, 54511, France
Espace Artois Santé
Arras, Pas-de-Calais, 62000, France
Centre Hospitalier Universitaire Nord
Saint-Étienne-de-Montluc, Pays de la Loire Region, 42055, France
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, Puy-de-Dôme, 63000, France
Hôpital Edouard Herriot
Lyon, Rhône, 69003, France
Centre Hospitalier Universitaire d'Amiens
Amiens, Somme, 80054, France
Cabinet libéral Besancon - polyclinique des Fleurs
Ollioules, Var, 83190, France
Clinique des Fleurs
Ollioules, Var, 83190, France
Cabinet libéral Richard
Sanary-sur-Mer, Var, 83110, France
Cabinet libéral Ben Sedrine
Six-Fours-les-Plages, Var, 83140, France
Cabinet libéral Riviere
Six-Fours-les-Plages, Var, 83140, France
Cabinet libéral Zimmermann
Six-Fours-les-Plages, Var, 83140, France
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Toulon, Var, 83056, France
Hôpital Saint Joseph
Paris, 75674, France
Centre d'explorations vasculaires
Paris, Île-de-France Region, 75116, France
Related Publications (24)
Ageno W, Squizzato A, Wells PS, Buller HR, Johnson G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost. 2013 Aug;11(8):1597-602. doi: 10.1111/jth.12301. No abstract available.
PMID: 23682905BACKGROUNDAguilar C, del Villar V. Combined D-dimer and clinical probability are useful for exclusion of recurrent deep venous thrombosis. Am J Hematol. 2007 Jan;82(1):41-4. doi: 10.1002/ajh.20754.
PMID: 16947316BACKGROUNDBates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, Kearon C, Schunemann HJ, Crowther M, Pauker SG, Makdissi R, Guyatt GH. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e351S-e418S. doi: 10.1378/chest.11-2299.
PMID: 22315267BACKGROUNDFraser DG, Moody AR, Morgan PS, Martel AL, Davidson I. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med. 2002 Jan 15;136(2):89-98. doi: 10.7326/0003-4819-136-2-200201150-00006.
PMID: 11790060BACKGROUNDGeersing GJ, Zuithoff NP, Kearon C, Anderson DR, Ten Cate-Hoek AJ, Elf JL, Bates SM, Hoes AW, Kraaijenhagen RA, Oudega R, Schutgens RE, Stevens SM, Woller SC, Wells PS, Moons KG. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ. 2014 Mar 10;348:g1340. doi: 10.1136/bmj.g1340.
PMID: 24615063BACKGROUNDGoodacre S, Sampson F, Thomas S, van Beek E, Sutton A. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging. 2005 Oct 3;5:6. doi: 10.1186/1471-2342-5-6.
PMID: 16202135BACKGROUNDHamadah A, Alwasaidi T, LE Gal G, Carrier M, Wells PS, Scarvelis D, Gonsalves C, Forgie M, Kovacs MJ, Rodger MA. Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence. J Thromb Haemost. 2011 Dec;9(12):2406-10. doi: 10.1111/j.1538-7836.2011.04533.x.
PMID: 21985174BACKGROUNDHassen S, Barrellier MT, Seinturier C, Bosson JL, Genty C, Long A, Pernod G. High percentage of non-diagnostic compression ultrasonography results and the diagnosis of ipsilateral recurrent proximal deep vein thrombosis: a rebuttal. J Thromb Haemost. 2011 Feb;9(2):414-6; author reply 417-8. doi: 10.1111/j.1538-7836.2010.04137.x. No abstract available.
PMID: 21070594BACKGROUNDHeijboer H, Jongbloets LM, Buller HR, Lensing AW, ten Cate JW. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. Acta Radiol. 1992 Jul;33(4):297-300.
PMID: 1633039BACKGROUNDHull RD, Carter CJ, Jay RM, Ockelford PA, Hirsch J, Turpie AG, Zielinsky A, Gent M, Powers PJ. The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge. Circulation. 1983 Apr;67(4):901-6. doi: 10.1161/01.cir.67.4.901.
PMID: 6825247BACKGROUNDKearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7.
PMID: 26867832BACKGROUNDLe Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Perrier A, Bounameaux H. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism. Arch Intern Med. 2006 Jan 23;166(2):176-80. doi: 10.1001/archinte.166.2.176.
PMID: 16432085BACKGROUNDLe Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Perrier A, White RH, Vickars L, Rodger M. Validation of a diagnostic approach to exclude recurrent venous thromboembolism. J Thromb Haemost. 2009 May;7(5):752-9. doi: 10.1111/j.1538-7836.2009.03324.x. Epub 2009 Feb 18.
PMID: 19228281BACKGROUNDLinkins LA, Stretton R, Probyn L, Kearon C. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res. 2006;117(3):241-7. doi: 10.1016/j.thromres.2005.02.011. Epub 2005 Mar 21.
PMID: 16378830BACKGROUNDPrandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, Noventa F, Benedetti L, Girolami A. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation. 1993 Oct;88(4 Pt 1):1730-5. doi: 10.1161/01.cir.88.4.1730.
PMID: 8403319BACKGROUNDPrandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A; DERECUS Investigators Group. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost. 2002 Sep;88(3):402-6.
PMID: 12353067BACKGROUNDPrandoni P, Tormene D, Dalla Valle F, Concolato A, Pesavento R. D-dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis. J Thromb Haemost. 2007 May;5(5):1076-7. doi: 10.1111/j.1538-7836.2007.02455.x. Epub 2007 Mar 15. No abstract available.
PMID: 17367489BACKGROUNDRathbun SW, Whitsett TL, Raskob GE. Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial. Ann Intern Med. 2004 Dec 7;141(11):839-45. doi: 10.7326/0003-4819-141-11-200412070-00007.
PMID: 15583225BACKGROUNDSchulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Larfars G, Leijd B, Linder O, Loogna E. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med. 1997 Feb 6;336(6):393-8. doi: 10.1056/NEJM199702063360601.
PMID: 9010144BACKGROUNDTan M, Velthuis SI, Westerbeek RE, VAN Rooden CJ, VAN DER Meer FJ, Huisman MV. High percentage of non-diagnostic compression ultrasonography results and the diagnosis of ipsilateral recurrent proximal deep vein thrombosis. J Thromb Haemost. 2010 Apr;8(4):848-50. doi: 10.1111/j.1538-7836.2010.03758.x. No abstract available.
PMID: 20398187BACKGROUNDTan M, Bornais C, Rodger M. Interobserver reliability of compression ultrasound for residual thrombosis after first unprovoked deep vein thrombosis. J Thromb Haemost. 2012 Sep;10(9):1775-82. doi: 10.1111/j.1538-7836.2012.04827.x.
PMID: 22726359BACKGROUNDTan M, Mol GC, van Rooden CJ, Klok FA, Westerbeek RE, Iglesias Del Sol A, van de Ree MA, de Roos A, Huisman MV. Magnetic resonance direct thrombus imaging differentiates acute recurrent ipsilateral deep vein thrombosis from residual thrombosis. Blood. 2014 Jul 24;124(4):623-7. doi: 10.1182/blood-2014-04-566380. Epub 2014 Jun 13.
PMID: 24928859BACKGROUNDvan der Hulle T, Tan M, den Exter PL, van Roosmalen MJ, van der Meer FJ, Eikenboom J, Huisman MV, Klok FA. Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism. Haematologica. 2015 Feb;100(2):188-93. doi: 10.3324/haematol.2014.112896. Epub 2014 Sep 26.
PMID: 25261098BACKGROUNDWesterbeek RE, Van Rooden CJ, Tan M, Van Gils AP, Kok S, De Bats MJ, De Roos A, Huisman MV. Magnetic resonance direct thrombus imaging of the evolution of acute deep vein thrombosis of the leg. J Thromb Haemost. 2008 Jul;6(7):1087-92. doi: 10.1111/j.1538-7836.2008.02986.x. Epub 2008 Jul 1.
PMID: 18433464BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Antoine Elias, MD
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2019
First Posted
March 11, 2019
Study Start
January 17, 2020
Primary Completion
January 30, 2023
Study Completion
January 30, 2023
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share